首页> 外国专利> Human sperm fibrous sheath (FS) proteins: new target antigens for use in therapeutic cancer vaccines and diagnostic screening and Methods of Using Same

Human sperm fibrous sheath (FS) proteins: new target antigens for use in therapeutic cancer vaccines and diagnostic screening and Methods of Using Same

机译:人精子纤维鞘(FS)蛋白:用于治疗性癌症疫苗和诊断性筛选的新靶标抗原及其使用方法

摘要

Cancer vaccines were demonstrated to be promising strategies for cancer treatment but the strategies are limited by the paucity of target antigens that provoke an effective immune response. We propose that sperm fibrous sheet proteins constitute a new class of potential antigens for cancer vaccines. This hypothesis is supported by the expression of the sperm fibrous sheath protein known as Sperm protein 17 detected in tumors of unrelated histological origin. It has the ability to induce T-cell based immune responses. The expression of the Sperm protein 17 (Sp17) in tumors of unrelated histological origin, and its natural localization in the human sperm fibrous sheath (FS), led us to hypothesize that FS proteins might represent a new potential class of target antigens useful for developing cancer vaccines and diagnostic and therapeutic treatments.
机译:已证明癌症疫苗是用于癌症治疗的有前途的策略,但是该策略受到激发有效免疫反应的靶抗原的缺乏的限制。我们建议,精子纤维片蛋白构成癌症疫苗的一类新的潜在抗原。在不相关的组织学起源的肿瘤中检测到的称为精子蛋白17的精子纤维鞘蛋白的表达支持了该假设。它具有诱导基于T细胞的免疫反应的能力。精子蛋白17(Sp17)在无关组织学起源的肿瘤中的表达及其在人类精子纤维鞘(FS)中的自然定位,使我们假设FS蛋白可能代表了一种新的潜在靶抗原,可用于开发癌症疫苗以及诊断和治疗方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号